Lerner Lorena Raquel
Chief Scientific Officer
Lerner Lorena Raquel has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 20, 2026.
On the most recent filing, Lerner Lorena Raquel is listed as Chief Scientific Officer at Keros Therapeutics, Inc. Inside the rolling window, Lerner Lorena Raquel reported no open-market purchases and 2 open-market sales totaling $100K in KROS. The largest disclosed transaction in the window is a sale of 3,873 KROS shares on Feb 18, 2026, worth $63K.
Companies traded
Other insiders at KROS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$100K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Lerner Lorena Raquel made?
Lerner Lorena Raquel has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Lerner Lorena Raquel trade?
Lerner Lorena Raquel has filed SEC Form 4 disclosures for 1 company, including KROS.
When was Lerner Lorena Raquel's most recent SEC Form 4 filing?
Lerner Lorena Raquel's most recent SEC Form 4 filing on Tracefour is dated Aug 20, 2026.
What is Lerner Lorena Raquel's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lerner Lorena Raquel is listed as Chief Scientific Officer.
What is Lerner Lorena Raquel's total buy and sell value in the current window?
Inside the rolling retention window, Lerner Lorena Raquel bought $0 and sold $100K based on SEC Form 4 filings.
What was Lerner Lorena Raquel's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,873 KROS shares on 2026-02-18, worth $63K, per SEC Form 4 filings.